Myths vs facts: Triglyceride senken and longevity

Lowering triglycerides is often linked to longevity, but the evidence requires nuance. It is well-established that elevated triglycerides (≥150 mg/dL) are an independent risk factor for cardiovascular events, which can shorten lifespan. Lifestyle interventions (reducing refined carbs, increasing omega-3s, exercise) effectively lower triglycerides and reduce heart attack and stroke risk. However, no large randomized controlled trial has directly proven that triglyceride reduction alone extends total lifespan – benefits are confounded by improvements in HDL, insulin sensitivity, and inflammation. Genetic studies (e.g., LPL and APOC3 variants) suggest a causal role, but these findings are population-level and not directly actionable for individuals. A common myth is that extremely low triglycerides (<50 mg/dL) are automatically beneficial; in reality, they may indicate malnutrition or underlying disease. Bottom line: Managing triglycerides is important for cardiovascular health, but longevity depends on a broader metabolic and lifestyle picture. Consumers should not rely solely on a single biomarker; comprehensive testing (glucose, HbA1c, inflammation markers) and evidence-based lifestyle changes are key.